BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33019935)

  • 1. COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
    Fatone MC
    Curr Rheumatol Rev; 2021; 17(1):7-16. PubMed ID: 33019935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?
    Sacchi MC; Tamiazzo S; Lauritano EC; Bonometti R
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11960-11963. PubMed ID: 33275270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.
    Tang KT; Hsu BC; Chen DY
    Front Immunol; 2021; 12():645013. PubMed ID: 33777042
    [No Abstract]   [Full Text] [Related]  

  • 5. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of autoimmunity induced by SARS-CoV-2 and development of post-vaccination autoimmune diseases].
    Montaño-Armendáriz N; Zamudio-Cuevas Y; Fernández-Torres J; Martínez-Flores K; Luján-Juárez IA
    Rev Alerg Mex; 2023 Jan; 69(2):78-88. PubMed ID: 36928248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intersection of COVID-19 and autoimmunity.
    Knight JS; Caricchio R; Casanova JL; Combes AJ; Diamond B; Fox SE; Hanauer DA; James JA; Kanthi Y; Ladd V; Mehta P; Ring AM; Sanz I; Selmi C; Tracy RP; Utz PJ; Wagner CA; Wang JY; McCune WJ
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34710063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases.
    Saad MA; Alfishawy M; Nassar M; Mohamed M; Esene IN; Elbendary A
    Curr Rheumatol Rev; 2021; 17(2):193-204. PubMed ID: 33121413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
    Novelli L; Motta F; De Santis M; Ansari AA; Gershwin ME; Selmi C
    J Autoimmun; 2021 Feb; 117():102592. PubMed ID: 33401171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer.
    Meroni PL; Borghi MO
    Ann Rheum Dis; 2021 Sep; 80(9):1105-1107. PubMed ID: 34340980
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.
    Taherifard E; Taherifard E; Movahed H; Mousavi MR
    Hematology; 2021 Dec; 26(1):225-239. PubMed ID: 33594951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.
    Gracia-Ramos AE; Martin-Nares E; Hernández-Molina G
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
    Alunno A; Carubbi F; Rodríguez-Carrio J
    RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
    Mussa BM; Srivastava A; Verberne AJM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases.
    Lakota K; Perdan-Pirkmajer K; Hočevar A; Sodin-Semrl S; Rotar Ž; Čučnik S; Žigon P
    Front Immunol; 2020; 11():611318. PubMed ID: 33574819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.